TRIO PHARMA ApS: Financial statements 2022
CVR: 36499281
Source: annual report 2022, Danish Business Authority
01/05/2021 – 30/04/2022
TRIO PHARMA ApS (CVR 36499281) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -423,140 and a net result of DKK 9,019,563 compared with DKK -151,784 the year before. Equity in the 2022 report amounted to DKK -43,630. The company had 1 employee in the financial year.
- Gross Profit
- DKK -423,140
- Profit/Loss
- DKK 9,019,563
- Equity
- DKK -43,630
- Total Assets
- DKK 240,783
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -423 t. | 9 mio. | -44 t. | 1 |
| 2021 | - | 361 t. | -152 t. | -1.3 mio. | 1 |
| 2020 | - | 85 t. | -361 t. | -1.1 mio. | 1 |
| 2019 | - | 134 t. | -232 t. | -750 t. | - |
| 2018 | - | 28 t. | -272 t. | -518 t. | - |
Official annual report
Keep an eye on TRIO PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of May 30, 2022, inforevision statsautoriseret revisionsaktieselskab has stepped down as auditor of TRIO PHARMA ApS.
As of April 12, 2022, STINE RATJE HOLDING ApS is registered as an owner of TRIO PHARMA ApS with an ownership share of 10%.
As of April 12, 2022, CHRISTIAN RATJE HOLDING ApS is registered as an owner of TRIO PHARMA ApS with an ownership share of 90%.
About TRIO PHARMA ApS
TRIO PHARMA ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2015. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Christian Bo Ratje. The board consists of Michael John Ratje (chair), Christian Bo Ratje and Kirstine Laura Ratje-Johansen. The company is owned by STINE RATJE HOLDING ApS and CHRISTIAN RATJE HOLDING ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK -411,555 and a net result of DKK -1,170,880 compared with DKK -489,664 the year before. Equity in the 2025 report amounted to DKK -2,593,533.